Plain-English translation of NCT07423429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study examines whether switching patients to — a higher dose of an eye injection used to treat age-related macular degeneration — helps when standard treatments stop working or require frequent injections. Researchers will review the medical records of patients who made this switch as part of their regular eye care, comparing how they did before and after the change.
Some patients with age-related macular degeneration don't respond well to standard eye injection treatments, or they need injections so frequently that it becomes a burden. This study aims to understand whether this medication at a higher dose can help these patients need fewer injections and maintain or improve their vision.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means researchers will review your existing medical records — you won't need to attend new visits or receive new treatments. Doctors at participating eye centers in Western France will collect information about your vision, eye imaging results, and injection history from the 12 months before and after you switched medications, then analyze this data to see how the treatment change affected your outcomes.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
France